Company Filing History:
1 out of 989 
1 out of 14 Years Active: 2013
Title: Kunio Iwatani: Innovator in Polyglutamine Aggregation Treatment
Introduction
Kunio Iwatani is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of diseases caused by polyglutamine aggregation. His innovative work has the potential to impact many lives.
Latest Patents
Iwatani holds a patent for an agent designed to treat polyglutamine aggregation-caused diseases or to suppress their onset. The patent, titled "Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof," includes as active ingredients either HGF protein, a partial peptide of HGF protein that is substantially equivalent in activity to HGF protein, or a salt of either of them. He has 1 patent to his name.
Career Highlights
Throughout his career, Kunio Iwatani has worked with prestigious institutions, including Osaka University and Kringle Pharma Inc. His research and development efforts have focused on advancing medical treatments and understanding complex diseases.
Collaborations
Iwatani has collaborated with esteemed colleagues such as Toshikazu Nakamura and Hiroshi Funakoshi. Their combined expertise has contributed to the advancement of research in their field.
Conclusion
Kunio Iwatani's innovative work in treating polyglutamine aggregation-caused diseases showcases his dedication to medical science. His contributions are paving the way for future advancements in this critical area of research.